Since the pandemic struck the world, working from home is more popular than ever before. Even for some people, working from home has now become their new normal. And some of us enjoy the flexibility and find it much easier to get our tasks done at home. Just Think No hour-long commutes, no complicated wardrobe,…
Merck Expects COVID-19 Pill Molnupiravir to Be Effective Against Omicron
January 12, 2022
admin
AMERICABusiness & EconomyBusinesses in COVID-19CCP VirusCompanieseffectiveExpectmerckmolnupiravirOmicronWorld
0 Comment
Merck’s COVID-19 oral pill molnupiravir has a mechanism of action that can work against Omicron and any other variant, a company executive said on Monday. “We’re very confident that it will effect Omicron … This mechanism in molecule (will) work for Omicron, and I would imagine against any variant that comes up,” Dean Li, president…
Regeneron Says Its COVID-19 Antibody Cocktail May Be Less Effective Against Omicron
Regeneron said on Nov. 30 that its COVID-19 antibody drug cocktail could lose effectiveness against Omicron, providing further indication that the arsenal of medical products developed to fight the disease may need modification to be effective against the new strain. The drugmaker said in a statement (pdf) that early tests show that the high number…
LIVE: Texas COVID-19 Summit: Are COVID-19 Vaccines Safe and Effective?
Experts in the medical profession will provide answers on the safety and effectiveness of COVID-19 vaccines and safe and effective options for treatment. The experts will present data-supported information about early treatment and prevention of COVID-19. Join the LIVE summit Nov. 21, from 3:00pm to 7:00pm EST. Speakers: Dr. Peter McCullough Dr. Bryan Ardis Dr….
Texas COVID-19 Summit: Are COVID-19 Vaccines Safe and Effective?
Experts in the medical profession will provide answers on the safety and effectiveness of COVID-19 vaccines and safe and effective options for treatment. The experts will present data-supported information about early treatment and prevention of COVID-19. Join the LIVE summit Nov. 21, from 3:00pm to 7:00pm EST. Speakers: Dr. Peter McCullough Dr. Bryan Ardis Dr….
AstraZeneca Antibody Cocktail 77 Percent Effective Against Symptomatic COVID-19 in Trial
August 20, 2021
admin
antibody cocktailAstrazenecaCCP ViruseffectiveHealth NewsMind & BodyPUBLIC HEALTH INFORMATIONTechVaccines & SafetyWorld
0 Comment
AstraZeneca said Friday it plans to apply for regulatory approval of an antibody cocktail that a preliminary study showed was highly effective in preventing symptomatic COVID-19, offering a potential alternative or complement to vaccines. The Anglo-Swedish drugmaker announced in an Aug. 20 release that the drug, a combination of two long-acting antibodies derived from convalescent…
3 Questions That Will Change Your Mindset from Busy to Strategic
By Jessica Foutty Just about every time I ask someone how they are doing, they reply with something akin to, “Busy, but good.” There’s so much that demands our attention, from ads to scrolling through social media to work calls to family activities. While I realize everyone is fractionally or wholly overcommitted, with me being…
Israel Reports 39 Percent Effectiveness of Pfizer Vaccine in Halting Delta Variant Infections: Reports
Israeli health officials on Thursday reported that Pfizer’s COVID-19 vaccine is just 39 percent effective in preventing infections with the more contagious Delta variant, while noting that the vaccine remains highly effective in preventing serious illness and hospitalization, according to reports. New statistics from Israel’s Health Ministry, released Thursday, indicated that the vaccine jointly developed…
Pfizer COVID-19 Shot 91 Percent Effective in Updated Data, Protective Against South African Variant
Pfizer Inc and BioNTech’s COVID-19 vaccine is around 91 percent effective at preventing the disease, they said on Thursday, citing updated trial data that included participants inoculated for up to six months. The shot was also 100 percent effective in preventing illness among trial participants in South Africa, where a new variant called B1351 is…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`